Recursion Pharmaceuticals, Inc. Class A Common Stock RXRX
$3.68
-3.92%
at last close
Market Cap$2.29 billion
P/E Ratio—
Div Yield—
Volume20.81M
52-Week Range
$2.77$7.18
Analyst Ratings
- Consensus
- Moderate Buy — 2 Buy · 2 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $7.63 (+107.2% upside)
Key Stats
- Today's Range
- $3.65 – $4.08
- 50-Day Range
- $3.10 – $5.19
- 52-Week Range
- $2.77 – $7.18
- Volume
- 20.81 million shs
- Average Volume
- 27.71 million shs
- Market Cap
- $2.29 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.29%
- Days to Cover
- 1.39
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Related Stocks
Compare head-to-head: RXRX vs AMGN·RXRX vs MRNA·RXRX vs HALO·RXRX vs KYMR
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.